Asia Pacific Clinical Nutrition Market

The Asia Pacific clinical nutrition market size was USD 3.83 Billion in 2022 and is likely to reach USD 7.14 Billion by 2031, expanding at a CAGR of 7.17% during 2023–2031. The growth of the market is attributed to the increasing frequency of metabolic disorders, neurological illnesses, and rising elderly population.

A clinical nutrition product is a sort of medication that aids in the health of a patient. By supplying appropriate supplements such as minerals, vitamins, and other nutrients, it aids in the improvement of the metabolic system.

Get Free Sample Report

Clinical nutrition diagnoses and treats problems that impact dietary intake, intestinal absorption, and metabolism, as well as promoting health via diet-related disease prevention. It is used in cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.

The COVID-19 pandemic is projected to have a significant impact on the clinical nutrition products market, as need for nutritional management continues to rise, particularly among youngsters and the elderly. Consumers are looking for various immunity-boosting alternatives to avoid getting infected by the new coronavirus, which is driving up demand for clinical nutrition products.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing frequency of metabolic disorders and neurological illnesses is projected to fuel the market during the forecast period.

• Rising elderly population is key factor propelling the market in the coming years.

• Variable structure of government coverage and reimbursement between nations are estimated to hinder the market growth.

• Lack of awareness act as major challenge that can impede the market expansion in the coming years.

• R&D investment and technological advancement is expected to create lucrative opportunities for the market players.

Scope of Asia Pacific Clinical Nutrition Market Report

The report on the Asia Pacific clinical nutrition market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Asia Pacific Clinical Nutrition Market Segment Insights

The oral & enternal segment is projected to hold a major market share

Based on, the Asia Pacific clinical nutrition market is divided into oral & enternal and parental. The oral & enternal segment is expected to represent a key share of the market during the forecast period. In terms of value, oral clinical nutrition has the biggest share of  market.

The oral and enteral modes of delivery are the most commonly used for clinical nutrition, followed by the parenteral route. The oral route is the recommended method of administration for clinical nutrition as long as the patients can take food orally and their stomach and intestinal functions are not impaired.

The nutritional support in cancer segment is expected to grow at a rapid pace

On the basis of application, the Asia Pacific clinical nutrition market is segmented into nutritional support in malnutrition, nutritional support in metabolic disorders, nutritional support in gastrointestinal diseases, nutritional support in neurological diseases, nutritional support in cancer, and nutritional support in other diseases.

The nutritional support in cancer segment is expected to represent a key share of the market during the forecast period due to increasing number of people suffering from chronic diseases like cancer and diabetes, as well as a growing geriatric population base. Patients suffering from chronic illnesses are deficient in a number of critical nutrients, which has prompted an increase in clinical nutrition prescriptions.

Get Free Sample Report

The pediatric segment is anticipated to expand at a rapid pace

In terms of end-user, the Asia Pacific clinical nutrition market is bifurcated into pediatric and adult. The pediatric segment is expected to represent a key share of the market during the forecast period. Pediatrics holds the major share of the market and is projected to maintain its dominance throughout the forecast period. Concerns regarding malnutrition in children are likely to be a significant growth factor in the Asia Pacific clinical nutrition products market.

India is expected to dominate the market

On the basis of geography, the Asia Pacific clinical nutrition market is classified as China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific. The market of India is anticipated to dominate the market during the forecast period.

The market demand for clinical nutrition, particularly baby feeding products, is expected to be fueled by countries with high birth rates, such as India and China. According to the World Bank group, India has the highest birth rate in the APAC area, followed by China.

Segments

The Asia Pacific clinical nutrition market has been segmented on the basis of

Route of Administration

• Oral & Enternal
• Parental

Application

• Nutritional Support in Malnutrition
• Nutritional Support in Metabolic Disorders
• Nutritional Support in Gastrointestinal Diseases
• Nutritional Support in Neurological Diseases
• Nutritional Support in Cancer
• Nutritional Support in Other Diseases

End-user

• Pediatric
• Adult

Geography

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Key Players

• Nutricia
• Abbott Nutrition
• Nestle Healthcare Science
• B. Braun Melsungen AG
• Baxter Healthcare

Competitive Landscape

Key players competing in the Asia Pacific clinical nutrition market include Nutricia, Abbott Nutrition, Nestle Healthcare Science, B. Braun Melsungen AG, and Baxter Healthcare.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.